Evidence map›Paper›PMID 27776981›Full record

ReviewChest2017

Asthma Metabolomics and the Potential for Integrative Omics in Research and the Clinic.

Rachel S Kelly, Amber Dahlin, Michael J McGeachie, Weiliang Qiu, Joanne Sordillo, Emily S Wan, Ann Chen Wu, Jessica Lasky-Su

Open access · bronzeAbstract readReview
In one paragraph

Review in Chest, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 112 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
112citing papers in PubMed, 3 pooled it
8.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

112 citing papers in PubMed, 3 syntheses or guidelines pooled it, 170 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. The Human Respiratory Microbiome: Current Understandings and Future Directions.American journal of respiratory cell and molecular biology · 2023
    Pooled it
  4. Serum 25-hydroxyvitamin D, metabolome, and bronchiolitis severity among infants-A multicenter cohort study.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2018
    Trial
  5. Trial
  6. Metabolomic profiling of lung function in Costa-Rican children with asthma.Biochimica et biophysica acta. Molecular basis of disease · 2017
    Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Asthma endotypes and theratypes.Chinese medical journal pulmonary and critical care medicine · 2026
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Multi-omics identifies severe asthma endotypes linked toThe World Allergy Organization journal · 2025
    Article
  20. Biomarker Discovery in Childhood Asthma: A Pilot Study of Serum Metabolite Analysis for IgE-Dependent Allergy.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Article

52 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Rachel S KellyChanning Division of Network Medicine, Brigham Women's Hospital and Harvard Medical School, Boston, MA.
Amber DahlinChanning Division of Network Medicine, Brigham Women's Hospital and Harvard Medical School, Boston, MA.
Michael J McGeachieChanning Division of Network Medicine, Brigham Women's Hospital and Harvard Medical School, Boston, MA.
Weiliang QiuChanning Division of Network Medicine, Brigham Women's Hospital and Harvard Medical School, Boston, MA.
Joanne SordilloDepartment of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care, Boston, MA.
Emily S WanChanning Division of Network Medicine, Brigham Women's Hospital and Harvard Medical School, Boston, MA; VA Boston Healthcare System, Department of Veterans Affairs, Boston, MA.
Ann Chen WuDepartment of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care, Boston, MA.
Jessica Lasky-SuChanning Division of Network Medicine, Brigham Women's Hospital and Harvard Medical School, Boston, MA. Electronic address: rejas@channing.harvard.edu.
Harvard University · USBrigham and Women's Hospital · USHarvard Pilgrim Health Care · USVA Boston Healthcare System · US

Funding

Integrative Metabolomics of Asthma SeverityR01HL123915 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI LASKY-SU, JESSICA A · 2014 to 2023
$7.0M
Age-Dependent Pharmacogenomics of Asthma Treatment (ADAPT)R01HD085993 · NICHD · HARVARD PILGRIM HEALTH CARE, INC. · PI WU, ANN CHEN · 2016 to 2020
$3.1M
Role of microRNA molecules in therapeutic response to leukotriene modifying agents in asthmaK01HL130629 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI DAHLIN, AMBER · 2016 to 2020
$818k
The epigenetics of exercise and physical activity in COPDIK2RX002165 · VA · VA BOSTON HEALTH CARE SYSTEM · PI WAN, EMILY S · 2016 to 2021
–
NHLBI NIH HHS K01 HL130629NHLBI NIH HHS R01 HL123915NICHD NIH HHS R01 HD085993RRD VA IK2 RX002165
6 · The paper itself

Abstract

Asthma is a complex disease well-suited to metabolomic profiling, both for the development of novel biomarkers and for the improved understanding of pathophysiology. In this review, we summarize the 21 existing metabolomic studies of asthma in humans, all of which reported significant findings and concluded that individual metabolites and metabolomic profiles measured in exhaled breath condensate, urine, plasma, and serum could identify people with asthma and asthma phenotypes with high discriminatory ability. There was considerable consistency across the studies in terms of the reported biomarkers, regardless of biospecimen, profiling technology, and population age. In particular, acetate, adenosine, alanine, hippurate, succinate, threonine, and trans-aconitate, and pathways relating to hypoxia response, oxidative stress, immunity, inflammation, lipid metabolism and the tricarboxylic acid cycle were all identified as significant in at least two studies. There were also a number of nonreplicated results; however, the literature is not yet sufficiently developed to determine whether these represent spurious findings or reflect the substantial heterogeneity and limited statistical power in the studies and their methods to date. This review highlights the need for additional asthma metabolomic studies to explore these issues, and, further, the need for standardized methods in the way these studies are conducted. We conclude by discussing the potential of translation of these metabolomic findings into clinically useful biomarkers and the crucial role that integrated omics is likely to play in this endeavor.

Indexed as

MetabolomicsAsthmaBiomarkersBreath TestsCitric Acid CycleHumansHypoxiaInflammationLipid MetabolismOxidative StressBiomarkersasthmabiomarkersintegrative omicsmetabolomicsproteomics

Identifiers

PMID27776981
PMCPMC5310123
OpenAlexW2535737554

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.